ConductScience.org, home

Paper7905693

Successful prevention of neurological deficit in SAH patients with 2-chlorodeoxyadenosine.

Ryba M and 7 others. Acta Neurochir (Wien), 1993. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Successful prevention of neurological deficit in SAH patients with 2-chlorodeoxyadenosine. Papers, record 7905693. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7905693

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Successful prevention of neurological deficit in SAH patients with 2-chlorodeoxyadenosine.
PubMed
Journal
Acta Neurochir (Wien)
PubMed
Year
1993
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.21
iCite
Revised in PubMed
2019-08-14
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ryba MM
2Grieb PP
3Pastuszko MM
4Bidziński JJ
5Andrychowski JJ
6Dziewiecki CC
7Bojarski PP
8Królicki LL

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aneurysm, RupturedMajor topic
CladribineMajor topic
Intracranial AneurysmMajor topic
Neurologic ExaminationMajor topic
PremedicationMajor topic
Subarachnoid HemorrhageMajor topic
Adult
Brain
Combined Modality Therapy
Dose-Response Relationship, Drug
Female
Glasgow Coma Scale
Humans
Infusions, Intravenous
Ischemic Attack, Transient
Male
Middle Aged
Postoperative Complications
Tomography, Emission-Computed, Single-Photon
Tomography, X-Ray Computed

Source PubMed

Download CSV of topics

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
181014192-Chloro-2' deoxyadenosine prevents angiopathic changes in cerebral arteries in experimental SAH in rabbits.Acta Neurochir (Wien)1993https://conductscience.org/library/papers/8101419PubMed
21711764Immunomodulators interfere with angiopathy but not vasospasm after subarachnoid haemorrhage in rabbits.Acta Neurochir (Wien)1991https://conductscience.org/library/papers/1711764PubMed
313465752-Chlorodeoxyadenosine treatment of lymphoid malignancies.Blood1992https://conductscience.org/library/papers/1346575PubMed
43895589Cerebral vasospasm following aneurysmal subarachnoid hemorrhage.Stroke1985https://conductscience.org/library/papers/3895589PubMed
56136305Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes.Blood1983https://conductscience.org/library/papers/6136305PubMed
6274632042-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive Nucleoside.Leuk Lymphoma1991https://conductscience.org/library/papers/27463204PubMed
77354892Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning.Neurosurgery1980https://conductscience.org/library/papers/7354892PubMed
82360460Acute surgery in intracranial aneurysms. Experience with 100 cases.Acta Neurochir (Wien)1990https://conductscience.org/library/papers/2360460PubMed
92687689Cyclosporine.N Engl J Med1989https://conductscience.org/library/papers/2687689PubMed
101680554On the pharmacokinetics of 2-chloro-2'-deoxyadenosine in humans.Cancer Res1991https://conductscience.org/library/papers/1680554PubMed
111880509Single photon emission computed tomography in patients with acute hydrocephalus or with cerebral ischaemia after subarachnoid haemorrhage.J Neurol Neurosurg Psychiatry1991https://conductscience.org/library/papers/1880509PubMed
123131498Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale.J Neurosurg1988https://conductscience.org/library/papers/3131498PubMed
1313468012-Chlorodeoxyadenosine treatment of low-grade lymphomas.J Clin Oncol1992https://conductscience.org/library/papers/1346801PubMed
144136544Assessment of coma and impaired consciousness. A practical scale.Lancet1974https://conductscience.org/library/papers/4136544PubMed
1546957Assessment of outcome after severe brain damage.Lancet1975https://conductscience.org/library/papers/46957PubMed
16665338Timing and indication of surgery for ruptured intracranial aneurysms with regard to cerebral vasospasm.Acta Neurochir (Wien)1978https://conductscience.org/library/papers/665338PubMed
171700795Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.J Clin Invest1990https://conductscience.org/library/papers/1700795PubMed
182024283Cyclosporine A for the prevention of neurological deficit following subarachnoid hemorrhage.Stroke1991https://conductscience.org/library/papers/2024283PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7905693

GET https://conductscience.org/api/papers/v1/7905693/authors